Clinical Trial Update: Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML) [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial assesses bleximenib in combination with standard induction/consolidation therapy followed by maintenance for adults with acute myelo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Bleximenib (Bleximenib)

Snippet

Sponsor: Stichting Hemato-Oncologie voor Volwassenen Nederland | Conditions: Acute Myeloid Leukemia | Phase 3 | Status: RECRUITING